What are the real procedural costs of bariatric surgery? A systematic literature review of published cost analyses by Doble, B, Wordsworth, S, Rogers, C, Welbourne, R, Byrne, J, Blazeby, J, By-Band-Sleeve Trial Management Group

Early stage anal margin cancer: towards evidence‐based management by Renehan, A, Muirhead, R, Berkman, L, McParland, L, Sebag-Montefiore, D, Plato Trial Management Group, Hawkins, M

Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study by Sally Wheelwright, Lucy Matthews, Valerie Jenkins, Shirley May, Daniel Rea, Pat Fairbrother, Claire Gaunt, Jennie Young, Sarah Pirrie, Matthew G. Wallis, Lesley Fallowfield, on behalf of the LORIS Trial Management Group

Get full text

Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial by Jon Griffin, Jenny Down, Lewis A Quayle, Paul R Heath, Ewan A Gibb, Elai Davicioni, Yang Liu, Xin Zhao, Jayne Swain, Dennis Wang, Syed Hussain, Simon Crabb, James WF Catto, the GUSTO Trial Management Group

Get full text

Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection by L. Baxter, N. S. Gordon, S. Ott, J. Wang, P. Patel, A. Goel, K. Piechocki, L. Silcock, C. Sale, M. P. Zeegers, K. K. Cheng, N. D. James, The BladderPath trial management group, R. T. Bryan, D. G. Ward

Get full text

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer by Robert C Stein, Janet A Dunn, John MS Bartlett, Amy F Campbell, Andrea Marshall, Peter Hall, Leila Rooshenas, Adrienne Morgan, Christopher Poole, Sarah E Pinder, David A Cameron, Nigel Stallard, Jenny L Donovan, Christopher McCabe, Luke Hughes-Davies, Andreas Makris, on behalf of the OPTIMA Trial Management Group

Get full text

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols by Schiavone, F, Bathia, R, Letchemanan, K, Masters, L, Amos, C, Bara, A, Brown, L, Gilson, C, Pugh, C, Atako, N, Hudson, F, Parmar, M, Langley, R, Kaplan, RS, Parker, C, Attard, G, Clarke, NW, Gillessen, S, James, ND, Maughan, T, Sydes, MR, The Stampede And Focus4 Trial Management Group

A comparison of health professionals’ and patients’ views of the importance of outcomes of bariatric surgery by Coulman, K, Howes, N, Hopkins, J, Whale, K, Chalmers, K, Brookes, S, Nicholson, A, Savovic, J, Ferguson, Y, Owen-Smith, A, Blazeby, J, By-Band-Sleeve Trial Management Group, Blazeby, J, Welbourn, R, Byrne, J, Donovan, J, Reeves, B, Wordsworth, S, Andrews, R, Thompson, J, Mazza, G, Rogers, C

Ruxolitinib induces changes in histone modification status in patients entered into the MAJIC clinical trial by McPherson, S, Harrison, C, Mead, A, Mills, K, McMullin, M

Other Authors: “…MAJIC clinical trial management group…”